TICLID Drug Patent Profile
✉ Email this page to a colleague
When do Ticlid patents expire, and what generic alternatives are available?
Ticlid is a drug marketed by Roche Palo and is included in one NDA.
The generic ingredient in TICLID is ticlopidine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the ticlopidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ticlid
A generic version of TICLID was approved as ticlopidine hydrochloride by APOTEX on July 1st, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TICLID?
- What are the global sales for TICLID?
- What is Average Wholesale Price for TICLID?
Summary for TICLID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 113 |
Clinical Trials: | 1 |
Patent Applications: | 1,935 |
DailyMed Link: | TICLID at DailyMed |
Recent Clinical Trials for TICLID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dammam Central Hospital | Phase 4 |
Dammam University | Phase 4 |
King Fahad Armed Forces Hospital | Phase 4 |
US Patents and Regulatory Information for TICLID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-001 | Mar 24, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-002 | Oct 31, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TICLID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-001 | Mar 24, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-002 | Oct 31, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-002 | Oct 31, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-001 | Mar 24, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TICLID
See the table below for patents covering TICLID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 507645 | ⤷ Sign Up | |
Netherlands | 7706097 | ⤷ Sign Up | |
France | 2336932 | ⤷ Sign Up | |
Sweden | 7608691 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |